Neurobiological mechanisms underlying resiliency and vulnerability to opioid use disorder
阿片类药物使用障碍的弹性和脆弱性的神经生物学机制
基本信息
- 批准号:10740556
- 负责人:
- 金额:$ 19.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAttenuatedBehaviorBehavioralBehavioral ModelCellsCharacteristicsCluster AnalysisComplexConfocal MicroscopyCuesDendritesDendritic SpinesDevelopmentDiameterDiseaseDrug RegulationsElectrophysiology (science)FOS ProteinFemaleGeneticGlobus PallidusHabenulaHeadHeroinHeterogeneityHumanImmunohistochemistryIndividualLabelLateralLinkMeasuresMediatingModelingMorphologyN-MethylaspartateNetwork-basedNeurobiologyNeuronal PlasticityNeuronsNucleus AccumbensOutputPathway interactionsPhasePhenotypePopulationPrediction of Response to TherapyProcessRattusRegulationRelapseReporterRewardsRodent ModelSignal TransductionStructureStructure of subthalamic nucleusSubstance Use DisorderSymptomsSynaptic PotentialsTechniquesTestingTracerTrainingTreatment EfficacyUnited StatesVertebral columnViralWorkaddictionbehavioral phenotypingcareerdensitydrug seeking behaviorexperimental studyfunctional plasticitygenetic approachgenetic technologyheroin usehuman modelindividual variationinsightmalenetwork modelsneural circuitneurobiological mechanismnovelopioid use disorderoptogeneticspatch clamppostsynapticpromote resilienceprotein biomarkersresilienceresponsetrait
项目摘要
PROJECT SUMMARY/ABSTRACT
There has been a significant rise in opioid use disorder (OUD) in the United States over the past decade, making
it imperative to gain a better understanding of the behavioral characteristics underlying OUD vulnerability.
Current rodent models focus on how one or few traits interact in a linear manner to predict substance use disorder
(SUD), however, OUD consists of several symptoms that interact with one another across the addiction process
and can vary between individuals to affect OUD vulnerability or resiliency. I contributed toward a rat model that
captures this behavioral complexity using male and female heterogeneous stock rats in an effort to better model
human OUD. Bayesian stochastic block model (SBM) network-based clustering analysis is used to separate rats
into resilient and vulnerable subpopulations. Using this model, we are able to assess the neurobiological
mechanisms contributing toward OUD vulnerability and resiliency, the latter of which is not well understood.
These opposing phenotypes are likely mediated by different cellular and circuitry adaptations, and will be the
focus of this proposal. The K99 aims assess how functional and morphological neuroplasticity differences in
nucleus accumbens core (NAcc) D1/D2 medium-spiny neuron (MSN) contribute to OUD resiliency and
vulnerability. I will first use whole-cell patch-clamp electrophysiology to characterize changes in AMPA/NMDA
ratios in vulnerable and resilient subpopulations following cued reinstatement (Aim 1). I will then inject an
intracellular label into the recorded cell and examine differences in D1/D2-MSN dendritic spine morphology (Aim
2). This approach will allow for the tracking of NAcc neuroplastic adaptations within the same cell across the two
phenotypes. The R00 portion of the proposal will assess how pathway specific regulation of dorsolateral ventral
pallidum (dlVP) projections contribute to OUD resiliency and vulnerability. Comparable to the NAcc, the dlVP,
the main functional output of the NAcc, shows cell-specific functional regulation of drug seeking and refraining
behavior, making it an ideal structure to evaluate circuit heterogeneity in individual variation in OUD propensity.
Using confocal microscopy and viral tracers, I will assess functional connectivity from the dlVP to the subthalamic
nucleus (STN), a region known to enhance seeking and likely vulnerability, and to the lateral habenula (LHb),
known to mediate aversion and hypothesized to promote resiliency (Aim 3a). I will then employ chemogenetic
technology to selectively isolate and manipulate these pathways in OUD resilient and vulnerable rats. (Aim 3b).
Lastly, using whole-cell patch-clamp electrophysiology, I will evaluate input adaptations in the STN and LHb
following dlVP stimulation within the two phenotypes following cued reinstatement (Aim 4). Experiments in this
proposal employ a novel rat model capturing individual variation in OUD propensity similar to what is observed
in humans. Work from this proposal will greatly contribute to our knowledge of the cellular and circuitry
mechanisms contributing to OUD resiliency versus vulnerability.
项目总结/摘要
在过去的十年中,美国阿片类药物使用障碍(OUD)显著增加,
更好地理解OUD脆弱性背后的行为特征势在必行。
目前的啮齿动物模型集中在一个或几个性状如何以线性方式相互作用来预测物质使用障碍
(SUD)然而,OUD由几种症状组成,这些症状在成瘾过程中相互作用
并且可以在个体之间变化以影响OUD脆弱性或弹性。我为一个老鼠模型做了贡献,
利用雄性和雌性异质大鼠捕捉这种行为复杂性,以更好地建模
人OUD。采用基于贝叶斯随机块模型(SBM)网络的聚类分析方法对大鼠进行分类
适应能力强的和脆弱的亚群。使用这个模型,我们能够评估神经生物学
导致OUD脆弱性和弹性的机制,后者尚未得到很好的理解。
这些相反的表型可能是由不同的细胞和电路适应介导的,并且将成为
这一提案的重点。K99的目的是评估功能和形态神经可塑性的差异,
延髓核核心(NAcc)D1/D2中棘神经元(MSN)有助于OUD弹性,
易损性.我将首先使用全细胞膜片钳电生理学来表征AMPA/NMDA的变化,
在线索恢复后,脆弱和弹性亚群的比率(目标1)。然后我会注射
细胞内标记到记录的细胞中,并检查D1/D2-MSN树突棘形态的差异(目的
2)。这种方法将允许在两个细胞中追踪同一细胞内的NAcc神经可塑性适应。
表型该提案的R 00部分将评估背外侧腹侧神经元的通路特异性调节
苍白球(dlVP)预测有助于OUD的弹性和脆弱性。与NAcc,dlVP,
NAcc的主要功能输出,显示了药物寻找和抑制的细胞特异性功能调节
行为,使其成为一个理想的结构,以评估电路的异质性在个别变化的OUD倾向。
使用共聚焦显微镜和病毒示踪剂,我将评估从dlVP到丘脑底核的功能连接,
核(Numbers),一个已知增强寻求和可能的脆弱性的区域,以及外侧缰核(LHb),
已知调解厌恶和假设,以促进弹性(目标3a)。然后我会用化学遗传学
技术选择性地隔离和操纵这些通路在OUD弹性和脆弱的大鼠。(Aim 3 b)。
最后,使用全细胞膜片钳电生理学,我将评估输入的适应,在小脑和LHb
在线索恢复后的两种表型中,在dlVP刺激后(目标4)。在这方面的实验
一个建议采用了一种新大鼠模型,该模型捕获了与所观察到的相似的OUD倾向的个体变化
在人类身上。这项工作将大大有助于我们的细胞和电路的知识
有助于OUD弹性与脆弱性的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brittany Nicole Kuhn其他文献
Brittany Nicole Kuhn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 19.07万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 19.07万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 19.07万 - 项目类别:
Research Grant